Results 171 to 180 of about 146,739 (334)

Development and Validation of a Liquid Chromatography High‐Resolution Mass Spectrometry Method for Blood Desmopressin Quantification and Its Application in Hemophilia A Patients

open access: yesRapid Communications in Mass Spectrometry, Volume 39, Issue 18, 30 September 2025.
ABSTRACT Desmopressin (DDAVP), which indirectly increases Coagulation Factor VIII concentrations in the blood, is a common treatment for bleeding disorders such as von Willebrand disease or hemophilia A. However, DDAVP exhibits significant variability in response due to interindividual differences in pharmacokinetics.
Sophie Hodin   +7 more
wiley   +1 more source

Von Willebrand disease (VWD) and pregnancy: a comprehensive overview. [PDF]

open access: yesThromb J
Soleimani Samarkhazan H   +5 more
europepmc   +1 more source

von Willebrand disease biology [PDF]

open access: yesHaemophilia, 2012
Blomback, M.   +4 more
openaire   +4 more sources

Bleeding Complications in JAK2‐Variant Essential Thrombocythemia: A Revisit in 2025

open access: yeseJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterised by sustained thrombocytosis. Paradoxically, bleeding complications remain an under‐recognised clinical challenge. Compared with CALR‐mutated patients, those harbouring the JAK2‐V617F variant appear more prone to haemorrhage.
Gerard Gurumurthy   +4 more
wiley   +1 more source

A prospective diagnostic accuracy study evaluating rotational thromboelastometry and thromboelastography in 100 patients with von Willebrand disease

open access: yesHaemophilia, 2017
David E. Schmidt   +7 more
semanticscholar   +1 more source

Post‐Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential Thrombocythemia

open access: yeseJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Objectives The present study investigated the effects of thrombosis, hemorrhagic events, disease progression, and secondary malignancies on patient survival after the diagnosis of essential thrombocythemia (ET). Methods We analyzed data from 1152 patients enrolled in the JSH‐MPN‐18 study using time‐dependent Cox regression and multistate ...
Yoshinori Hashimoto   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy